Notably, the effect of MBNL in ALS was specific for FUS, as muscleblind did not modify the phenotypes of fly and iPSC models of TDP-43-, VCP-, and C9ORF72 peptide-linked ALS. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.